Announcements

A Form 4 filed on August 13, 2026, with the U.S. Securities and Exchange Commission discloses that Richard M. Hutson II, a director of Investors Title Co (NASDAQ:ITIC), acquired 212 shares of common stock on August 12, 2026.

Apollo Global Management, Inc. filed a current report on Form 8-K with the SEC on August 13, 2026, disclosing that its subsidiary Athene Holding Ltd. hosted a Fixed Income Investor call that same day.

A Form 4 filed on August 13, 2026 discloses that Charles Fitzgerald, a director of Chiron Real Estate Inc. (NYSE:XRN), acquired 14,000 shares of common stock on August 11, 2026.

A Form 4 filed on August 13, 2026, with the SEC discloses that Mark Okey Decker Jr., CEO and President of Chiron Real Estate Inc. (NYSE:XRN), purchased 550 shares of common stock on August 11, 2026.

Olema Pharmaceuticals, Inc. filed a current report on Form 8-K on August 13, 2026, disclosing the appointment of Jason O'Byrne as Chief Financial Officer, principal financial officer, and principal accounting officer, effective August 11, 2026.

Sagimet Biosciences Inc. filed a Form 8-K on August 13, 2026, reporting that the U.S. Food and Drug Administration cleared the company's Investigational New Drug application and issued a "Study May Proceed" letter for a Phase 3 clinical trial of denifanstat in moderate to …

Rocket Lab Corporation filed a Form 8-K on August 13, 2026, disclosing the entry into an Equity Distribution Agreement with Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC to sell up to $1,944,369,826 of common stock through an at-the-market program, and separately announced …